Endotoxaemia Completed Phase 1 Trials for Tilarginine (DB11815)

Also known as: Endotoxemia / Endotoxemia (disorder)

IndicationStatusPhase
DBCOND0014110 (Endotoxaemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00185003Blockade of Vascular Potassium Channels During Human EndotoxemiaTreatment